Advanced Search

Home > Journals > Minerva Medica > Archive > Minerva Medica 2013 April;104(2) > Minerva Medica 2013 April;104(2):155-60

CURRENT ISSUE   ARCHIVE   EPUB AHEAD OF PRINT   MOST READ   eTOC


MINERVA MEDICA

Minerva Medica 2013 April;104(2):155-60

THROMBOSIS 

Myeloma and thrombotic complications

Tzoran I. 1, Brenner B. 1, 2, Hoffman R. 1, 2

1 Department of Hematology and Bone Marrow Transplantation Rambam Health Care Campus, Haifa, Israel;
2 Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel

Multiple myeloma (MM) is a hematological malignancy with high risk for thrombosis. While venous thromboembolism is more common, myeloma patients can also present with arterial thrombosis. Risk factors responsible for this complication can be patient-related, myeloma- and treatment-related. Thromboprophylaxis is indicated along with specific therapeutic regimens employed in myeloma patients. This review will cover potential risk factors for thrombosis in patients with multiple myeloma, prevention recommendations and treatment strategies in this clinical setting.

language: English


FULL TEXT  REPRINTS

top of page